United States oncologists’ clinical preferences regarding modes of medicinal cannabis use
Timothy S. Sannes,
Manan M. Nayak,
Stephanie Tung,
Peter R. Chai,
Miryam Yusufov,
Dragana Bolcic‐Jankovic,
William F. Pirl,
Ilana M. Braun
Affiliations
Timothy S. Sannes
Harvard Medical School Division of Adult Psychosocial Oncology and Palliative Care Dana Farber Cancer Institute 450 Brookline Avenue Boston MA 02215 USA
Manan M. Nayak
Harvard Medical School Division of Adult Psychosocial Oncology and Palliative Care Dana Farber Cancer Institute 450 Brookline Avenue Boston MA 02215 USA
Stephanie Tung
Harvard Medical School Division of Adult Psychosocial Oncology and Palliative Care Dana Farber Cancer Institute 450 Brookline Avenue Boston MA 02215 USA
Peter R. Chai
Harvard Medical School Division of Adult Psychosocial Oncology and Palliative Care Dana Farber Cancer Institute 450 Brookline Avenue Boston MA 02215 USA
Miryam Yusufov
Harvard Medical School Division of Adult Psychosocial Oncology and Palliative Care Dana Farber Cancer Institute 450 Brookline Avenue Boston MA 02215 USA
Dragana Bolcic‐Jankovic
Center for Survey Research University of Massachusetts Boston 100 Morrissey Blvd Boston MA 02125 USA
William F. Pirl
Harvard Medical School Division of Adult Psychosocial Oncology and Palliative Care Dana Farber Cancer Institute 450 Brookline Avenue Boston MA 02215 USA
Ilana M. Braun
Harvard Medical School Division of Adult Psychosocial Oncology and Palliative Care Dana Farber Cancer Institute 450 Brookline Avenue Boston MA 02215 USA
